⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Bandhan Focused Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | IDFC MF | HDFC MF |
| Category | Equity - Focused Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹101.26 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | BSE 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Manish Gunwani | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | -5.05% | 22.64% |
| 3Y | 14.88% | 30.41% |
| 5Y | 10.81% | — |
| Since Inception | 12.53% | 29.15% |
| Risk | ||
| 15.41 | 14.07 | |
| 1.01 | 0.59 | |
| 0.58 | 1.59 | |
| 8.57 | 21.67 | |
| 1.17 | 3.48 | |
| -10.68% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.98% | 1.03% |
| Exit Load | Nil upto 10% of investment and 1% for remaining investment on or before 365D, Nil after 365D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
IDFC MF98%
HDFC MF98%
2.1%Only 2.1% of holdings by weight are common between IDFC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingIDFC MFHDFC MF
Glenmark Pharmaceuticals Ltd.5.29%2.09%
Category context: Equity vs Equity. Open the full Screener →